Tamsulosin, the first prostate-selective α(1A)-adrenoceptor antagonist. Meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH)

European Urology

Volumn 29, Issue 2, 1996, Pages 155-167

  Chapple, R ^a   Wyndaele, J J ^a   Nordling, J ^a   Beuninghaus, F ^a   Ypma, A F G V M ^a   Abrams, P ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

(1A) Adrenergic receptor; 1 Adrenoceptor antagonists; Benign prostatic hyperplasia; Lower urinary tract symptoms; Receptor subtype; Tamsulosin

Indexed keywords

PLACEBO; TAMSULOSIN;

ADULT; AGED; ARTICLE; ASTHENIA; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERANCE; FOLLOW UP; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MICTURITION; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SOMNOLENCE; SYMPTOM; SYNCOPE; URINE FLOW RATE; VERTIGO;

ADMINISTRATION, ORAL; ADRENERGIC ALPHA-ANTAGONISTS; AGED; ANALYSIS OF VARIANCE; BLOOD PRESSURE; DOUBLE-BLIND METHOD; EUROPE; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PULSE; SULFONAMIDES; URINATION;

EID: 0030065315     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)